In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Electric cars, climate credit schemes, diverse boardrooms and legal weed: How California exports its ideas and policies across the U.S. For many of the hundreds of thousands of Venezuelan immigrants ...